Valo Health
Developing new medicines using an AI computational platform.
Company facts
- Founded
- 2019
- Employees
- 204
- Headquarters
- United States
- CEO
- Brian M. Alexander
- Type
- Private
- Funding
- Series B · $110M · 2021
- Subsidiaries
- TARA Biosystems, Courier Therapeutics, Numerate, TrialzOWN
About
Valo Health is pioneering a new approach to drug discovery and development, leveraging vast amounts of human data and artificial intelligence through its Opal Computational Platform™. Recognizing the slow and costly nature of traditional drug development processes, Valo is committed to revolutionizing this landscape by uniting machine learning, tissue biology, and patient data. This integration not only streamlines the entire drug development lifecycle but also significantly enhances the success rates of new therapies. The company assembles a diverse team of experts encompassing fields such as software engineering, data science, biology, and medicinal chemistry. This multidisciplinary approach fosters innovative solutions that harness the power of human-centric data, ultimately facilitating the discovery of transformative medicines. Valo’s focus is particularly strong in areas like cardiovascular, metabolic, and oncological diseases, aiming to tackle high unmet medical needs.
Open positions
Staff Data Scientist, Computational Biology
Staff Data Scientist in Computational Biology builds and owns AI-driven drug-discovery software, turning biology use cases into production-ready Python/R tools and APIs for target identification teams.
Staff Data Scientist, Machine Learning in Epidemiology and Patient Data Products
About Us Valo Health is a human-centric, AI-enabled biotechnology company working to make new drugs for patients faster. The company’s Opal Computational Platform transforms drug discovery and development through a…